Skip to main content

Table 4 Analysis of the relationship between the MTHFR methylation pattern and the C677T polymorphism of MTHFR and biochemical, inflammatory and oxidative stress variables

From: The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients

 

Methylated (42)

Partially methylated (65)

CC (21)

TC (18) + TT (3)

p

CC (30)

TC (33) + TT (2)

p

GLIC

Mean  ±  SD

Median

164.8 ± 56.3

139.0

180.1 ± 50.5

167.0

0.2273

158.2 ± 59.3

147.0

166.7 ± 69.4

152.0

0.6499

Min.–Max.

85.0–301.0

121.0–282.0

85.0–303.0

72.0–359.0

HbA1c

Mean  ±  SD

Median

8.5 ± 2.6

7.9

8.0 ± 1.2

8.0

0.9599

8.3 ± 1.7

8.3

8.3 ± 2.0

8.0

0.8332

Min.–Max.

5.3–14.4

5.7–11.1

4.1–110

4.7–12.7

TC

Mean  ±  SD

Median

185.8 ± 39.3

93.0

203.7 ± 56.2

133.0

0.5629

204.1 ± 56.8

187.0

188.2 ± 47.4

187.0

0.3570

Min.–Max.

93.0–272.0

133.0–145.0

127.0–320.0

96.0–316.0

HDL

Mean  ±  SD

Median

45.0 ± 9.6

46.0

44.6 ± 9.4

43.0

0.8800

42.1 ± 12.0

41.5

44.3 ± 11.2

43.0

0.3569

Min.–Max.

30.0–61.0

27.0–62.0

23.0–75.0

21.0–75.0

LDL

Mean  ±  SD

Median

109.3 ± 37.4

112.6

113.9 ± 56.1

103.6

0.9398

127.8 ± 52.2

117.5

106.2 ± 47.8

101.8

0.1388

Min.–Max.

29.4–177.0

29.0–227.0

46.8–251.6

30.0–215.6

TRIG

Mean  ±  SD

Median

172.2 ± 78.6

165.0

229.2 ± 131.4

207.0

0.1189

179.7 ± 87.5

170.5

203.8 ± 108.2

181.0

0.4454

Min.–Max.

55.0–329.0

56.0–650.0

67.0–488.0

53.0–484.0

CREA-S

Mean  ±  SD

Median

1.0 ± 0.3

0.7 ± 0.2

0.0080*

0.9 ± 0.4

0.8

0.9 ± 0.4

0.8

0.7372

Min.–Max.

0.5–1.8

0.4–1.2

0.5–2.2

0.5–2.2

M. ALB

Mean  ±  SD

Median

35.5 ± 50.4

15.0

48.7 ± 139.6

13.0

0.5627

66.4 ± 146.2

11.0

65.7 ± 151.7

18.0

0.8025

Min.–Max.

1.0–205.0

1.0–650.0

1.0–525.0

1.0–650.0

CRP

Mean  ±  SD

Median

3.6 ± 3.1

2.5

3.9 ± 3.3

4.1

0.8144

3.9 ± 3.6

2.8

3.0 ± 3.0

1.8

0.2496

Min.–Max.

0.6–11.9

0.4–13.3

0.3–11.7

0.1–11.7

AGP

Mean  ±  SD

Median

96.0 ± 44.3

89.5

83.7 ± 15.3

84.0

0.4652

80.9 ± 22.6

75.0

73.6 ± 31.3

70.0

0.2089

Min.–Max.

55.0–263.0

56.0–118.0

52.0–172.0

4.0–176.0

TAC

Mean  ±  SD

Median

54.2 ± 25.1

57.0

41.5 ± 29.9

42.0

0.2458

27.6 ± 27.8

13.0

24.2 ± 22.9

12.0

0.6262

Min.–Max.

8.0–94.0

5.0–91.0

4.0–96.0

2.0–82.0

MDA

Mean  ±  SD

Median

3.6 ± 1.1

3.7

3.7 ± 0.8

3.7

0.7916

3.5 ± 1.3

3.4

3.4 ± 1.3

3.7

0.8642

Min.–Max.

1.1–5.1

2.3–4.9

1.4–6.3

1.0–6.2

  1. HbA1C (%) glycated haemoglobin, GLIC (mg/dL) fasting glycemia, TC (mg/dL) total cholesterol, HDL (mg/dL) high density lipoprotein, LDL (mg/dL) light density lipoprotein cholesterol, TRIG (mg/dL) triglycerides, CREA-S (mg/dL) serum creatinine, M. ALB (mg/dL) 24 h albumin excreted in the urine, RCP (mg/dL) reactive C protein, AGP (mg/dL) alfa 1 acid glycoprotein, TAC (%) total antioxidant capacity, MDA (µM) malondialdehyde
  2. * Statistically significant (p < 0.05), Mann–Whitney test